Financhill
Buy
61

COPR Quote, Financials, Valuation and Earnings

Last price:
$0.4670
Seasonality move :
14.31%
Day range:
$0.4670 - $0.4670
52-week range:
$0.0520 - $0.4980
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
182
Avg. volume:
414
1-year change:
16.75%
Market cap:
$120.6M
Revenue:
--
EPS (TTM):
-$0.03
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $4.2M $3M
Other Inc / (Exp) -- -- -- $194.4K -$261.1K
Operating Expenses -- -- -- $4.2M $3M
Operating Income -- -- -- -$4.2M -$3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$4.3M -$3.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$4.3M -$3.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$4.3M -$3.7M
 
Basic EPS (Cont. Ops) -- -- -- -$0.18 -$0.02
Diluted EPS (Cont. Ops) -- -- -- -$0.18 -$0.02
Weighted Average Basic Share -- -- -- $24.2M $211.3M
Weighted Average Diluted Share -- -- -- $24.2M $211.3M
 
EBITDA -- -- -- -$4M -$3.3M
EBIT -- -- -- -$4M -$3.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$4.2M -$3M
Operating Income (Adjusted) -- -- -- -$4M -$3.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $436.7K $2.2M
Other Inc / (Exp) -- -- -- -$68.6K --
Operating Expenses -- -- -- $436.7K $2.2M
Operating Income -- -- -- -$436.7K -$2.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$580.5K -$2.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$580.5K -$2.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$580.5K -$2.4M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.01
Diluted EPS (Cont. Ops) -- -- -- -- -$0.01
Weighted Average Basic Share -- -- -- $210.4M $253.5M
Weighted Average Diluted Share -- -- -- $210.4M $253.5M
 
EBITDA -- -- -- -$505.3K -$2.2M
EBIT -- -- -- -$505.3K -$2.2M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$436.7K -$2.2M
Operating Income (Adjusted) -- -- -- -$505.3K -$2.2M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.3M $5.9M
Other Inc / (Exp) -- -- -- -$203.8K -$57.3K
Operating Expenses -- -- -- $1.3M $5.9M
Operating Income -- -- -- -$1.3M -$5.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$1.8M -$6.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$1.8M -$6.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$1.8M -$6.4M
 
Basic EPS (Cont. Ops) -- -- -- -$0.01 -$0.03
Diluted EPS (Cont. Ops) -- -- -- -$0.01 -$0.03
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -$1.5M -$5.9M
EBIT -- -- -- -$1.5M -$5.9M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$1.3M -$5.9M
Operating Income (Adjusted) -- -- -- -$1.5M -$5.9M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $107.4K $50.7K $1.2M $4.1M --
Other Inc / (Exp) -- -- -$203.8K -- --
Operating Expenses $107.4K $50.7K $1.2M $4.1M --
Operating Income -$107.4K -$50.7K -$1.2M -$4.1M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$107.4K -$50.7K -$1.7M -$4.4M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$107.4K -$50.7K -$1.7M -$4.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$107.4K -$50.7K -$1.7M -$4.4M --
 
Basic EPS (Cont. Ops) -$0.01 -$0.00 -$0.01 -$0.02 --
Diluted EPS (Cont. Ops) -$0.01 -$0.00 -$0.01 -$0.02 --
Weighted Average Basic Share $60.2M $60.2M $628.5M $724.9M --
Weighted Average Diluted Share $60.2M $60.2M $628.5M $724.9M --
 
EBITDA -$107.4K -$50.7K -$1.4M -$4.1M --
EBIT -$107.4K -$50.7K -$1.4M -$4.1M --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$107.4K -$50.7K -$1.2M -$4.1M --
Operating Income (Adjusted) -$107.4K -$50.7K -$1.4M -$4.1M --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents -- -- -- $431.4K $30.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $21.6K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $431.4K $51.8K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $531.4K $151.8K
 
Accounts Payable -- -- -- $354.8K $434.5K
Accrued Expenses -- -- -- $92.2K $1.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $446.9K $1.9M
 
Long-Term Debt -- -- -- $3.4M $3.8M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $5.2M $6.2M
 
Common Stock -- -- -- $208.5K $214.7K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -$4.6M -$6.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$4.6M -$6.1M
 
Total Liabilities and Equity -- -- -- $531.4K $151.8K
Cash and Short Terms -- -- -- $431.4K $30.2K
Total Debt -- -- -- -- --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents -- -- -- $17.7K $18.7K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $24.5K $134.7K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $42.2K $153.5K
 
Property Plant And Equipment -- -- -- -- $20.8K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $142.2K $274.3K
 
Accounts Payable -- -- -- $477.8K $386K
Accrued Expenses -- -- -- $336.1K $673.3K
Current Portion Of Long-Term Debt -- -- -- -- $546K
Current Portion Of Capital Lease Obligations -- -- -- -- $20.8K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $813.9K $1.7M
 
Long-Term Debt -- -- -- $3.7M $2.6M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $6M $5.8M
 
Common Stock -- -- -- $213.2K $256.9K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- $12K
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$5.8M -$5.6M
 
Total Liabilities and Equity -- -- -- $142.2K $274.3K
Cash and Short Terms -- -- -- $17.7K $18.7K
Total Debt -- -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -- -- -- -$4.3M -$3.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $2.8M $2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$147.6K -$868.4K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $361K $202.2K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $361K $467.2K
 
Beginning Cash (CF) -- -- -- $218K $431.4K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $213.4K -$401.2K
Ending Cash (CF) -- -- -- $431.4K $30.2K
 
Levered Free Cash Flow -- -- -- -$147.6K -$868.4K
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -- -- -- -$580.5K -$2.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- $1.7M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$35.2K -$472.5K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $25K
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $37K
 
Beginning Cash (CF) -- -- -- $52.9K $454.3K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$35.2K -$435.5K
Ending Cash (CF) -- -- -- $17.7K $18.7K
 
Levered Free Cash Flow -- -- -- -$35.2K -$472.5K
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders -- -- -- -$1.8M -$6.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $140.7K $4.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$614.9K -$2.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $201.2K $2.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $1K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$614.9K -$2.3M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders -$107.4K -$50.7K -$1.7M -$4.4M --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- $140.7K $2.3M --
Change in Accounts Receivable $119.1K -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$68.7K -- -$614.9K -$2.1M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $201.2K $25K --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $68.7K -- -- -- --
Cash From Financing $68.7K -- $201.2K $2.1M --
 
Beginning Cash (CF) -- -- $601K $1.5M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$413.7K -$11.4K --
Ending Cash (CF) -- -- $187.4K $1.5M --
 
Levered Free Cash Flow -$68.7K -- -$614.9K -$2.1M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 31

Ajinomoto [AJINY] is down 2.15% over the past day.

Sell
40
RGC alert for Mar 31

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
69
AGX alert for Mar 31

Argan [AGX] is down 4.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock